ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3881 | Rec_0003881 | Mytilin G1 |
VVTCGSLCKAHCTFRKCGYFMSVLYHGRCYCRCLLC |
Mytilus galloprovincialis [Animal] |
Antimicrobial |
fungi F-oxysporum |
>5.6 μM | MIC |
- | - |
YES |
| 3882 | Rec_0003882 | Anal 4 |
AKKVFKRLEKSFSKIQNDK |
synthetic construct [Synthetic] |
Antimicrobial,Antibacterial,Antifungal,Anti-Gram-positive,Anti-Gram-negative |
Bacillus subtilis |
6.25 μM | MIC |
16255716 | - |
YES |
| 3883 | Rec_0003883 | Act Beta-defensin 2 (18-40)[C12I,C-del] |
RCPGRTRQIGTIFGPRIKCRSW |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Escherichia coli MG1655 |
4 μM | LC |
25791057 | - |
YES |
| 3884 | Rec_0003884 | Unnamed |
DGGRNFLRF |
not reported [other] |
Neuropeptide |
- |
- | - |
25931458;32786686 | - |
NO |
| 3885 | Rec_0003885 | Omiganan |
ILRWPWWPWRRK |
synthetic construct [Synthetic] |
Antibacterial |
Enterobacter cloacae |
128 μg/mL | MIC |
19524411 | - |
YES |
| 3886 | Rec_0003886 | FK13-a4 (Derived from FK13) |
FKRWVQRWKRFLR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Anti-Gram-positive, Anti-Gram-negative, Hemolytic |
- |
- | - |
28161291 | - |
NO |
| 3887 | Rec_0003887 | Unnamed |
GS |
Bos taurus [Animal]; Poaceae [Plant]; Pisum sativum [Plant]; Sus scrofa [Animal]; Gallus gallus [Animal]; Fabaceae [Plant] |
Antihypertensive |
- |
- | - |
20941517 | - |
NO |
| 3888 | Rec_0003888 | Pc-CATH1 |
RIKRFWPVVIRTVVAGYNLYRAIKKK |
Phasianus colchicus [Animal] |
Antimicrobial, Antibacterial, Antifungal, Anti-Gram-positive, Anti-Gram-negative |
Staphylococcus aureus |
2.95 μM | MIC |
20955730 | - |
YES |
| 3889 | Rec_0003889 | Insulin-like growth factor II |
AYRPSETLCGGELVDTLQFVCGDRGFYFSRPASRVNRRSRGIVEECCFRSCDLALLETYCATPAKSE |
Sus scrofa [Animal] |
Hormone, Endocrine, Metabolic regulation, Physiological regulation, Growth regulation, Development regulation, Receptor modulation, ACE inhibitory |
- |
- | - |
2809477 | - |
YES |
| 3890 | Rec_0003890 | Δ10-19[D5A]GeXIVA |
RSPYARRRRY |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer |
- |
- | - |
26170295 | CN112010966A |
NO |
| 3891 | Rec_0003891 | Unnamed |
SAYPGQITSN |
not reported [other] |
Antihypertensive, ACE inhibitory |
Angiotensin-converting enzyme (ACE) |
- | - |
- | - |
YES |
| 3892 | Rec_0003892 | Unnamed |
TVYGAFDPLLAVAD |
not reported [other] |
Antidiabetic, Type 1 diabetes-related, Metabolic regulation, Glucose metabolism, Signaling peptide, Regulatory peptide |
metabolic/glucose regulation; regulatory pathway |
- | - |
34478499 | - |
NO |
| 3893 | Rec_0003893 | dipeptide |
XII |
synthetic construct [Synthetic] |
- |
- |
- | - |
- | - |
NO |
| 3894 | Rec_0003894 | P1 |
GLGSVFGRLARILGRVIPKV |
synthetic construct [Synthetic] |
Antimicrobial, Antifungal |
Escherichia coli ML-35 |
2 μM | MIC |
- | - |
YES |
| 3895 | Rec_0003895 | C7A |
KILRGVAKKILRTFLRRISKDILTGKK |
Insecta [Animal] |
Anticancer |
- |
- | - |
23893605 | - |
NO |
| 3896 | Rec_0003896 | GS14 |
VKLKVYPLKVKLYP |
synthetic construct [Synthetic] |
Antimicrobial, Hemolytic |
Human erythrocytes |
10 μg/mL | Hemolysis |
10799508 | - |
YES |
| 3897 | Rec_0003897 | Neutrophil cationic antibacterial polypeptide CAP11 (1-18)m2, CAP11 (1-18)[G1K;K5L;T9L;R10,12L;Q14R;G17L] |
KLRKLFRKLLKLIRKLLR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Flavobacterium psychrophilum 1947 |
256 μg/mL | MIC |
26656394 | - |
YES |
| 3898 | Rec_0003898 | Unnamed |
AAAPGDEPAPP |
synthetic construct [Synthetic] |
Antimicrobial, Antiviral |
- |
- | - |
- | US 5859187 A |
NO |
| 3899 | Rec_0003899 | Ilamycin F |
XXLXAXX |
Streptomyces atratus SCSIO ZH16 [Bacterium] |
Antimicrobial, Antibacterial |
Enterococcus faecalis ATCC 29212 |
124.5 μM | MIC |
28855504 | - |
YES |
| 3900 | Rec_0003900 | Moricin II |
AMSLVSCSTAAPAKIPIKAIKTVGKAVGKGLRAINIASTANDVFNFLKPKKRKH |
Hyblaea puera [Animal] |
Antimicrobial |
- |
- | - |
- | - |
NO |